Upper Respiratory Disorders: Symptoms Comparison
Symptoms comparison of common upper respiratory disorders including the common cold, influenza, pharyngitis, allergic rhinitis, and the novel COVID-19.
Respiratory Infections
Vancomycin Injection Now Available in 4 Ready-to-Use Doses
Vanco Ready, a ready-to-use (RTU) vancomycin injection, has been made available by Xellia Pharmaceuticals.
Management of Mycobacterium chimaera Outbreak From Heater-Cooler Units
There is currently a global outbreak of disseminated Mycobacterium chimaera related to the widely used surgical device LivaNova 3T heater-cooler unit contamination.
CHEST Guidelines for Clinical Diagnosis of Pertussis-Associated Cough
In adult patients, pooled estimates of sensitivity and specificity were generated for 4 clinical features: paroxysmal cough, posttussive vomiting, inspiratory whoop, and absence of fever.
Radiography Still Common in Pediatric Bronchiolitis Despite AAP Guidelines
Despite recommendations made by the American Academy of Pediatrics, the use of radiography in pediatric bronchiolitis has not decreased.
Inhaled Corticosteroids Increase Risk for Pulmonary Nontuberculous Mycobacterial Infection
Patients with pulmonary nontuberculous mycobacterial infections were more likely to have used inhaled corticosteroids than patients with other airway disease.
Respiratory Tract Infection Telemedicine Visits Shorter When Antibiotics Prescribed
Findings may highlight physician difficulty explaining to patients why antibiotics are not required.
Amikacin Liposome Inhalation Plus Antibiotics Effective in MAC Lung Disease
Within 6 months, 23% of patients with Mycobacterium avium complex lung disease who had received add-on amikacin liposome inhalation suspension had a culture conversion.
Arikayce Approved to Treat Mycobacterium Avium Complex Lung Disease
Arikayce is intended for oral inhalation use and is administered via the Lamira Nebulizer System only.
Infant PPI Use and Lung Infection Risk: Is There a Link?
The data showed matched odds ratio for current vs past use of PPIs to be 0.88 (95% CI, 0.36 to 2.16) when comparing cases and their controls for community-acquired pneumonia. With regard to lower respiratory tract infections, the matched odds ratio between cases and their controls was 1.13 (95% CI, 0.87 to 1.48).
- Loading...
Loading...
Next post in Lung Infection
Loading... 
Loading...